Login to Pancreatic Cancer UK

Grand Challenge Award

Grand Challenge Web Banner Plus Text

Pancreatic Cancer UK Grand Challenge Award

After years of chronic underfunding, Pancreatic Cancer UK has been working hard to fund research to spur creative and cutting edge ideas and approaches in pancreatic cancer research and also to support, develop and attract the brightest minds in the pancreatic cancer field who will go on to make the breakthroughs of the future.

But so much more needs to be done.

Pancreatic cancer needs bold investment to transform the future and to deliver the step change that can alter the outcome for those diagnosed with this devastating disease.

That is why in 2016 we announced a £1m funding opportunity under Pancreatic Cancer UK’s Grand Challenge Award.

Under the Pancreatic Cancer UK Grand Challenge Award scheme, £1,000,000 was made available for a single project to tackle one or more of the major barriers or issues in pancreatic cancer, which when resolved would make a significant impact on the lives of those affected.

Applications were invited to address any priority area in pancreatic cancer research, but which included a clear vision of the programme of work, an issue to be addressed and a pathway to major impact and benefit for people affected by the disease. Under our Grand Challenge Award, teams should be based within the UK, with wider international collaborations where appropriate.

£1m was available for direct research costs, for a project of three to five years in duration.

Our competitive funding process saw applications from outstanding lead applicants, with supporting teams with a strong track record in pancreatic cancer research. One application was successfully awarded funding in March 2017, and there will be a full announcement and launch of our first ever Grand Challenge Award in Spring 2018.

Key dates:

Closing Date

SAB meeting



1pm on Tuesday 11 October 2016

February 2017

March 2017

Spring 2018


For any queries relating to the fund, please email the Pancreatic Cancer UK Research Team or call 020 7820 6705.